# Natco Pharma Limited – FDA Inspection, Aug 21, 2026

Source: https://www.keypedia.com/records/fda_inspections/natco-pharma-limited/b15c6908-585a-4b13-977b-36df87c1ddcd
Source feed: FDA_Inspections

> FDA inspection 1331920 of Natco Pharma Limited, August 21, 2026. 4 citations under 21 CFR part 211. Form 483 issued. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1331920
- Company Name: Natco Pharma Limited
- Inspection Date: 2026-08-21
- Project Area: Drug Quality Assurance
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Office of Inspections and Investigations
- Citation Count: 4

## Related Documents

- [FDA Inspection 1198251 - 2023-02-03](https://www.keypedia.com/records/fda_inspections/natco-pharma-limited/67af5a38-d989-41ea-9c1c-d6542387459a)

## Related Officers

- [Bryan L. Mcguckin](https://www.keypedia.com/people/bryan-l-mcguckin/33eaa16d-a642-4945-81f3-5d9ac180c2db)

Company: https://www.keypedia.com/companies/natco-pharma-limited/2684a2f8-36c9-4d09-8a48-2c7f17e0ac7d

Office: https://www.keypedia.com/offices/office-of-inspections-and-investigations/7dd0b904-a3df-46bc-a7b2-70ddb6f809c8